scholarly journals Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial

2016 ◽  
Vol 18 (5) ◽  
pp. 500-507 ◽  
Author(s):  
R. Aronson ◽  
Y. Reznik ◽  
I. Conget ◽  
J. A. Castañeda ◽  
S. Runzis ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Trial ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Sustained Efficacy ◽  
Multiple Daily Injections

scholarly journals Sustained Efficacy of Insulin Pump Therapy in Type 2 Diabetes: 9-Year Follow-up in a Cohort of 161 Patients: Table 1

Diabetes Care ◽  
2016 ◽  
Vol 39 (6) ◽  
pp. e74-e75 ◽  
Author(s):  
Julia Morera ◽  
Michael Joubert ◽  
Remy Morello ◽  
Anne Rod ◽  
Barbara Lireux ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Sustained Efficacy

Use of Insulin Pump Therapy in Patients with Type 2 Diabetes After Failure of Multiple Daily Injections

2013 ◽  
Vol 19 (1) ◽  
pp. 9-13 ◽  
Author(s):  
Matthew Leinung ◽  
Shannon Thompson ◽  
Mingfei Luo ◽  
Lina Leykina ◽  
Elizabeth Nardacci
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Multiple Daily Injections

Retrospective Analysis and Patient Satisfaction Assessment of Insulin Pump Therapy in Patients with Type 2 Diabetes

2011 ◽  
Vol 104 (1) ◽  
pp. 24-28 ◽  
Author(s):  
Chad K. Gentry ◽  
L. Brian Cross ◽  
Benjamin N. Gross ◽  
M. Shawn McFarland ◽  
William H. Bestermann
Keyword(s):  
Type 2 Diabetes ◽  
Patient Satisfaction ◽  
Retrospective Analysis ◽  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Pump Therapy

scholarly journals CopenFast trial: Faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy and lactation - a randomised controlled trial

BMJ Open ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. e045650
Author(s):  
Sidse Kjærhus Nørgaard ◽  
Elisabeth Reinhardt Mathiesen ◽  
Kirsten Nørgaard ◽  
Tine Dalsgaard Clausen ◽  
Peter Damm ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Pump ◽  
Controlled Trial ◽  
Insulin Pump Therapy ◽  
Pump Therapy ◽  
Acting Insulin ◽  
Pregnancy And Lactation ◽  
Randomised Controlled

IntroductionFaster-acting insulin aspart (Fiasp) is approved for use in pregnancy and lactation, but no clinical study has evaluated its effects during this life stage in women with pre-existing diabetes. The aim of the CopenFast trial is to evaluate the effect of Fiasp compared with insulin aspart (NovoRapid) on maternal glycaemic control during pregnancy, delivery and lactation and on fetal growth and infant health.Methods and analysisAn open-label randomised controlled trial of pregnant women with type 1 or type 2 diabetes including women on multiple daily injection (MDI) therapy or insulin pump therapy. During a 2-year inclusion period, approximately 220 women will be randomised 1:1 to Fiasp or NovoRapid in early pregnancy and followed until 3 months after delivery. At 9, 21 and 33 gestational weeks and during planned induction of labour or caesarean section, women are offered blinded continuous glucose monitoring (CGM) for 7 days. Randomisation will stratify for type of diabetes and insulin treatment modality (MDI or insulin pump therapy, respectively). Health status of the infants will be followed until 3 months of age. The primary outcome is birth weight SD score adjusted for gestational age and gender. Secondary outcomes include maternal glycaemic control including glycated haemoglobin, preprandial and postprandial self-monitored plasma glucose levels, episodes of mild and severe hypoglycaemia, maternal gestational weight gain and weight retention, CGM time spent in, above and below target ranges as well as pregnancy outcomes including pre-eclampsia, preterm delivery, perinatal mortality and neonatal morbidity. Data analysis will be performed according to the intention-to-treat principle.Ethics and disseminationThe trial has been approved by the Regional Ethics Committee (H-19029966) on 7 August 2019. Results will be sought disseminated in peer-reviewed journals and at scientific meetings.Trial registration numberNCT03770767

Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients

2005 ◽  
Vol 22 (8) ◽  
pp. 1037-1046 ◽  
Author(s):  
J. Wainstein ◽  
M. Metzger ◽  
M. Boaz ◽  
O. Minuchin ◽  
Y. Cohen ◽  
...  
Keyword(s):  
Insulin Pump ◽  
Insulin Pump Therapy ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Pump Therapy ◽  
Multiple Daily Injections ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document